Jane Street
RCUS icon

Jane Street’s Arcus Biosciences RCUS Stock Holding History

Jane Street’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33M Buy
107,979
+61,474
+132% +$1.33M ﹤0.01% 4794
2025
Q4 		$1.11M Sell
46,505
-179,127
-79% -$3.65M ﹤0.01% 5909
2025
Q3 		$3.07M Sell
225,632
-256,457
-53% -$2.67M ﹤0.01% 4177
2025
Q2 		$3.92M Buy
482,089
+377,487
+361% +$3.22M ﹤0.01% 3346
2025
Q1 		$821K Sell
104,602
-97,898
-48% -$1.14M ﹤0.01% 5938
2024
Q4 		$3.02M Sell
202,500
-14,541
-7% -$237K ﹤0.01% 3433
2024
Q3 		$3.32M Buy
217,041
+81,193
+60% +$1.28M ﹤0.01% 3536
2024
Q2 		$2.07M Buy
135,848
+60,939
+81% +$984K ﹤0.01% 4412
2024
Q1 		$1.41M Sell
74,909
-256,581
-77% -$4.44M ﹤0.01% 4764
2023
Q4 		$6.33M Buy
331,490
+220,191
+198% +$3.52M ﹤0.01% 2531
2023
Q3 		$2M Sell
111,299
-177,110
-61% -$3.56M ﹤0.01% 4059
2023
Q2 		$5.86M Buy
288,409
+252,847
+711% +$4.81M ﹤0.01% 2524
2023
Q1 		$649K Buy
35,562
+9,698
+37% +$185K ﹤0.01% 5864
2022
Q4 		$535K Sell
25,864
-7,967
-24% -$219K ﹤0.01% 6013
2022
Q3 		$885K Buy
33,831
+21,725
+179% +$575K ﹤0.01% 5630
2022
Q2 		$307K Sell
12,106
-12,755
-51% -$312K ﹤0.01% 7577
2022
Q1 		$785K Buy
+24,861
New +$833K ﹤0.01% 6625
2021
Q4 		– Sell
-22,515
Closed -$873K – 10691
2021
Q3 		$786K Buy
+22,515
New +$701K ﹤0.01% 6401
2021
Q2 		– Sell
-19,997
Closed -$562K – 10299
2021
Q1 		$562K Buy
19,997
+11,194
+127% +$390K ﹤0.01% 6583
2020
Q4 		$228K Sell
8,803
-6,107
-41% -$148K ﹤0.01% 6785
2020
Q3 		$256K Sell
14,910
-8,345
-36% -$186K ﹤0.01% 6105
2020
Q2 		$575K Buy
+23,255
New +$628K ﹤0.01% 4862
2019
Q1 		– Sell
-29,957
Closed -$323K – 5513
2018
Q4 		$323K Buy
+29,957
New +$350K ﹤0.01% 3981

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jane Street's RCUS Position: Q1 2026 in Review

Jane Street increased its Arcus Biosciences (RCUS) stake by 132% in Q1 2026, buying an estimated $1.33M and bringing the position to 107,979 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #4794.

Jane Street first reported a position in RCUS in Q4 2018 and has held it in 23 quarters since. The position peaked at $6.33M in Q4 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Jane Street held 107,979 shares of Arcus Biosciences worth $2.33M as of Q1 2026.
  • Jane Street bought 61,474 Arcus Biosciences shares in Q1 2026, an estimated $1.33M.
  • Arcus Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4794 holding.
  • Jane Street first reported a position in Arcus Biosciences in Q4 2018 and has held it in 23 quarters since.
  • Jane Street's Arcus Biosciences position peaked at $6.33M in Q4 2023.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.